Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse

Author(s):
Morgan, M.D.; Szeto, M.; Walsh, M.; Jayne, D.; Westman, K.; Rasmussen, N.; Hiemstra, T.F.; Flossmann, O.; Berden, A.; Hoglund, P.; Harper, L.; European Vasculitis Soc
Published
2017
Publication type
Article / Letter to editor
ANCAVasculitisRelapseTreatmentANCA-associated vasculitisClinical trialPrognostic factors
Date issued
2017-06-07
Language
English
Is part of
Arthritis Research and Therapy
hdl
1887/96064
doi
10.1186/s13075-017-1321-1